Vesica Health | Executive Team

Scientific Advisory Board

Our Scientific Advisory Board comprises a renowned group of world-leading bladder cancer experts who bring unparalleled scientific knowledge and clinical perspectives to guide our research and development initiatives.

Explore the profiles of our Advisory Board members to learn more about their backgrounds and the clinical expertise they contribute. Together, they provide critical guidance and strategic insights, ensuring we stay at the forefront of scientific advancements and maintain our commitment to excellence in patient care.

Peter Black, MD, FACS

Professor and Vice Chair, Department of Urologic Sciences, Khosrowshahi Family Chair, University of British Columbia Senior Research Scientist, Vancouver Prostate Centre, Associate Director of Clinical Research, Vancouver Prostate Centre Urologic Oncologist, Vancouver General Hospital

Medical School: Johannes Gutenberg University in Mainz, Germany; Fellowship: Urologic Oncology, MD Anderson Cancer Center; Residency: Urology, University of Washington, Seattle

Yair Lotan, MD

Professor of Urology, Chief of Urologic Oncology, Jane and John Justin Distinguished Chair in Urology, in Honor of Claus G. Roehrborn, M.D. at the University of Texas Southwestern Medical Center, Vice-Chair of Clinical Affairs in the Department of Urology, Head of the Clinical Research Office and Medical Director of the Urology Clinic at UT Southwestern and Parkland Health and Hospital System

Medical School: Baylor College of Medicine; Residency: Surgery & Urology, University of Texas, Southwestern

Sam S. Chang, MD, MBA

Professor, Department of Urology, Patricia and Rodes Hart Chair of Urologic Surgery, Chief Surgical Officer, Vanderbilt Ingram Cancer Center, Chief, Division of Urologic Oncology, Vanderbilt University School of Medicine

Medical School: Vanderbilt University School of Medicine; Master of Business Administration: Owen School of Business, at Vanderbilt; Fellowship: Urologic Oncology, Memorial Sloan-Kettering Cancer Center; Residency: Urology & Surgery, Vanderbilt University Medical Center

Sima P. Porten, MD, MPH

Associate Professor of Urology, University of California, San Francisco, Urologic Oncology, Helen Diller Family Comprehensive Cancer Center Program Director, Urologic Oncology Fellowship Program (UCSF)

Medical School: Northwestern University, Feinberg School of Medicine; Master Public Health: Northwestern University, Feinberg School of Medicine; Fellowship: Urologic Oncology, Univ of Texas, MD Anderson Cancer Center; Residency: Surgery & Urology, University of California, San Francisco

Siamak Daneshmand, MD

Professor of Clinical Urology, Clinical Scholar, Director of Urologic Oncology, USC Institute of Urology, Urologic Oncology (SUO) Fellowship Director, Keck School of Medicine of the University of Southern California

Medical School: University of California, Davis; Fellowship: Urologic Oncology, USC Norris Comprehensive Cancer Center; Residency: University of Southern California

Gary D. Steinberg, MD

Professor, Department of Urology, Rush University

Medical School: University of Chicago; Fellowship: Clinical Oncology, Johns Hopkins University; Residency: Urology, Brady Urological Institute at Johns Hopkins University; Residency: Surgery, Johns Hopkins University

Cheryl T. Lee, MD

Professor, Chair of Urology, Dorothy M. Davis Chair in Cancer Research, Department of Urology, Wexner Medical Center, Ohio State University

Medical School: Albany Medical College; Fellowship: Urologic Oncology, Memorial Sloan-Kettering Cancer Center; Fellowship: Urology, University of Michigan Hospitals; Internship: Surgery, University of Michigan Hospitals; Residency: Urology, University of Michigan Hospitals; Residency: Surgery, University of North Carolina Healthcare